Ledger.Open graph →
SEC Form D · filed September 9, 2019

ANSUN BIOPHARMA, INC

Offering
$100.0M
Sold
$78.4M
Exemption
Rule 506(b)
Industry
Other
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Vadim Khramov · Boca Raton, FLDirectorDon A. Mccarthy · New York, NYDirectorCP Collective Depositor, LLC · Newport Beach, CADirectorAdam I. Gunasekara · New York, NYDirectorLarry E. Chachkes · MIAMI BEACH, FLExec · DirectorCP Collective Apartments Manager, LLC · Newport Beach, CADirectorNina Barton · New York, NYDirectorMikael Havluciyan · San Diego, CAExecMikael Havluciyan · SAN DIEGO, CAExecThomas Casten · Hinsdale, ILDirectorSaurabh K. Srivastava · New York, NYDirectorBenjamin Maritz · SEATTLE, WADirectorKaren J. Jakobi · Irvine, CADirectorSachin K. Srivastava · New York, NYDirectorLisa Martensson · Dublin 1, IrelandDirectorPhilip M. Bilden · Palm Beach, FLDirectorBrian A. Meyer · New York, NYDirectorBill Hermann · Port Angeles, WADirectorKarl Mceneff · Dublin 1, IrelandExec · DirectorJohn Hamrock · Dublin 1, IrelandDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗